Efficacy of Pegylated Interferon Plus Ribavirin Plus Nitazoxanide in HCV Genotype 4 and HIV Coinfection
|ClinicalTrials.gov Identifier: NCT01529073|
Recruitment Status : Unknown
Verified January 2015 by Juan Macías, Andaluz Health Service.
Recruitment status was: Active, not recruiting
First Posted : February 8, 2012
Last Update Posted : January 14, 2015
Spanish National Health System
Information provided by (Responsible Party):
Juan Macías, Andaluz Health Service
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Unknown|
|Estimated Primary Completion Date :||February 2015|
|Estimated Study Completion Date :||February 2015|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Macías J, López-Cortés LF, Téllez F, Recio E, Ojeda-Burgos G, Ríos MJ, Rivero-Juárez A, Delgado M, Rivas-Jeremías, Pineda JA. Low Efficacy of Pegylated Interferon plus Ribavirin plus Nitazoxanide for HCV Genotype 4 and HIV Coinfection. PLoS One. 2015 Dec 7;10(12):e0143492. doi: 10.1371/journal.pone.0143492. eCollection 2015.